{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "31", "@year": "2021", "@timestamp": "2021-12-31T00:48:58.000058-05:00", "@month": "12"}, "ait:date-sort": {"@day": "01", "@year": "2017", "@month": "03"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding-addon-generated-timestamp": "2021-05-31T05:27:19.509Z", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "@afid": "60020352", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Vajira Hospital"}, {"$": "Navamindradhiraj University"}], "affiliation-id": [{"@afid": "60020352", "@dptid": "104032231"}, {"@afid": "60210153"}], "@dptid": "104032231"}, "author": [{"preferred-name": {"ce:given-name": "L.", "ce:initials": "L.", "ce:surname": "Boonyagars", "ce:indexed-name": "Boonyagars L."}, "@seq": "1", "ce:initials": "L.", "@_fa": "true", "@type": "auth", "ce:surname": "Boonyagars", "@auid": "57193608347", "ce:indexed-name": "Boonyagars L."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "organization": [{"$": "Department of Otolaryngology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425663"}, "@dptid": "104425663"}, "author": [{"preferred-name": {"ce:given-name": "P.", "ce:initials": "P.", "ce:surname": "Hirunwiwatkul", "ce:indexed-name": "Hirunwiwatkul P."}, "@seq": "2", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Hirunwiwatkul", "@auid": "6603372095", "ce:indexed-name": "Hirunwiwatkul P."}]}, {"affiliation": {"country": "Thailand", "address-part": "1873 Rama 4 Road", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Pathumwan, Bangkok", "organization": [{"$": "Biostatistics Center of Excellence"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "119005178"}, "@dptid": "119005178"}, "author": [{"preferred-name": {"ce:given-name": "C. P.", "ce:initials": "C.P.", "ce:surname": "Hurst", "ce:indexed-name": "Hurst C.P."}, "@seq": "3", "ce:initials": "C.P.", "@_fa": "true", "@type": "auth", "ce:surname": "Hurst", "@auid": "14013748700", "ce:indexed-name": "Hurst C.P."}]}], "citation-title": "CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients", "abstracts": "\u00a9 2017 The Union.OBJ E CTIVE S : Tuberculosis (TB) is a major cause of morbidity and mortality in human immunodeficiency virus (HIV) infected patients. However, anti-tuberculosis drugs can cause cutaneous adverse drug reactions (CADRs). This study was conducted to evaluate differences in CADR incidence between low and high CD4 cell count in patients with low and high CD4 cell count and to identify other risk factors for CADR in HIV-TB co-infected patients. DESIGN: In a retrospective cohort of adult HIV-TB coinfected patients receiving standard anti-tuberculosis treatment between January 2008 and December 2015 at Vajira Hospital, Bangkok, Thailand, baseline demographic, clinical characteristics and factors associated with CADRs, including CD4 cell count status, were collected. RESULT S : Of 307 patients enrolled, CADRs occurred in 48 during the 6-month period of anti-tuberculosis treatment (incidence rate 0.41 events/person-year). Maculopapular rash was the most prevalent CADR. Low CD4 cell count was not associated with CADRs. Cox regression analysis revealed that moderate decrease in the glomerular filtration rate, history of drug hypersensitivity and concomitant cotrimoxazole use were all associated with CADRs. Concomitant antiretroviral therapy usewas associatedwith lower risk of CADRs.No difference in the time to CADRs between patients with lower and higher CD4 cell count could be demonstrated. CONCLUS ION: CADRs are common in HIV-TB coinfected patients. Early recognition and prompt withdrawal of the offending agent can prevent complications and improve TB care.", "correspondence": {"affiliation": {"country": "Thailand", "address-part": "1873 Rama 4 Road", "postal-code": "10330", "@country": "tha", "city": "Pathumwan, Bangkok", "organization": [{"$": "Biostatistics Center of Excellence"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:initials": "C.P.", "ce:surname": "Hurst", "ce:indexed-name": "Hurst C.P."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "AIDS", "@xml:lang": "eng"}, {"$": "Drug allergy", "@xml:lang": "eng"}, {"$": "Mycobacterial infection", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": [{"@language": "English", "@xml:lang": "eng"}, {"@language": "French", "@xml:lang": "fre"}, {"@language": "Spanish", "@xml:lang": "spa"}]}, "source": {"website": {"ce:e-address": {"$": "http://docserver.ingentaconnect.com/deliver/connect/iuatld/10273719/v21n3/s18.pdf?expires=1489552038&id=90181789&titleid=3764&accname=Elsevier+BV&checksum=619155145DB3FEACEF011981EFB59B0C", "@type": "email"}}, "translated-sourcetitle": {"$": "International Journal of Tuberculosis and Lung Disease", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "21", "@issue": "3"}, "pagerange": {"@first": "338", "@last": "344"}}, "@type": "j", "sourcetitle": "International Journal of Tuberculosis and Lung Disease", "publicationdate": {"month": "03", "year": "2017", "date-text": {"@xfab-added": "true", "$": "1 March 2017"}, "day": "01"}, "codencode": "IJTDF", "sourcetitle-abbrev": "Int. J. Tuberc. Lung Dis.", "@country": "fra", "issn": [{"$": "18157920", "@type": "electronic"}, {"$": "10273719", "@type": "print"}], "publicationyear": {"@first": "2017"}, "publisher": {"publishername": "International Union against Tubercul. and Lung Dis.", "ce:e-address": {"$": "journal@the.union.org", "@type": "email"}}, "@srcid": "18502"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "13", "classification-description": "Dermatology and Venereology"}, {"classification-code": "15", "classification-description": "Chest Diseases, Thoracic Surgery and Tuberculosis"}, {"classification-code": "17", "classification-description": "Public Health, Social Medicine and Epidemiology"}, {"classification-code": "26", "classification-description": "Immunology, Serology and Transplantation"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "4", "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"}]}, {"@type": "ASJC", "classification": [{"$": "2740"}, {"$": "2725"}]}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": {"cas-registry-number": "8064-90-2", "chemical-name": "cotrimoxazole"}}, {"@source": "nlm", "chemical": [{"chemical-name": "Anti-HIV Agents"}, {"chemical-name": "Antitubercular Agents"}, {"chemical-name": "Trimethoprim, Sulfamethoxazole Drug Combination"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "05", "@year": "2017", "@timestamp": "BST 13:51:26", "@month": "04"}}, "itemidlist": {"itemid": [{"$": "614843751", "@idtype": "PUI"}, {"$": "662084000", "@idtype": "CAR-ID"}, {"$": "20170197587", "@idtype": "EMBASE"}, {"$": "20170486072", "@idtype": "REAXYSCAR"}, {"$": "85015255304", "@idtype": "SCP"}, {"$": "85015255304", "@idtype": "SGR"}, {"$": "620877120", "@idtype": "PUIsecondary"}, {"$": "28225346", "@idtype": "MEDL"}], "ce:doi": "10.5588/ijtld.16.0425"}}, "tail": {"bibliography": {"@refcount": "33", "reference": [{"ref-fulltext": "World Health Organization. HIV/AIDS [Internet]. Geneva, Switzerland: WHO, 2016. http://www. who. int/mediacentre/ factsheets/fs360/en/ Accessed February 2016.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "http://www.who.int/mediacentre/factsheets/fs360/en/", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "85104138383", "@idtype": "SGR"}}, "ref-text": "World Health Organization. Geneva, Switzerland: WHO Accessed February 2016", "ref-sourcetitle": "HIV/AIDS [Internet]"}}, {"ref-fulltext": "World Health Organization. Tuberculosis [Internet]. Geneva, Switzerland: WHO, 2016. http://www. who. int/mediacentre/ factsheets/fs104/en/ Accessed March 2016.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "http://www.who.int/mediacentre/factsheets/fs104/en/", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "85015203203", "@idtype": "SGR"}}, "ref-text": "World Health Organization. Tuberculosis [Internet]. Geneva, Switzerland: WHO, Accessed March 2016"}}, {"ref-fulltext": "World Health Organization. Data and statistics [Internet]. Geneva, Switzerland: WHO, 2016. http://www. who. int/hiv/ data/en/ Accessed March 2016.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "http://www.who.int/hiv/data/en/", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "85015167814", "@idtype": "SGR"}}, "ref-text": "World Health Organization. Data and statistics [Internet]. Geneva, Switzerland: WHO, Accessed March 2016"}}, {"ref-fulltext": "World Health Organization. Global tuberculosis report, 2015. WHO/HTM/TB/2015. 22. Geneva, Switzerland: WHO, 2015.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "refd-itemidlist": {"itemid": {"$": "84935892144", "@idtype": "SGR"}}, "ref-text": "World Health Organization. WHO/HTM/TB/2015. 22. Geneva, Switzerland: WHO", "ref-sourcetitle": "Global Tuberculosis Report, 2015"}}, {"ref-fulltext": "Coopman S A, Johnson R A, Platt R, Stern R S. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328:1670-1674.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "1993"}, "ref-title": {"ref-titletext": "Cutaneous disease and drug reactions in HIV infection"}, "refd-itemidlist": {"itemid": {"$": "0027174265", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "328"}, "pagerange": {"@first": "1670", "@last": "1674"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.A.", "@_fa": "true", "ce:surname": "Coopman", "ce:indexed-name": "Coopman S.A."}, {"@seq": "2", "ce:initials": "R.A.", "@_fa": "true", "ce:surname": "Johnson", "ce:indexed-name": "Johnson R.A."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Platt", "ce:indexed-name": "Platt R."}, {"@seq": "4", "ce:initials": "R.S.", "@_fa": "true", "ce:surname": "Stern", "ce:indexed-name": "Stern R.S."}]}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Temesgen Z, Beri G. HIV and drug allergy. Immunol Allergy Clin North Am 2004; 24: 521-531, viii.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "HIV and drug allergy"}, "refd-itemidlist": {"itemid": {"$": "3042783029", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "521", "@last": "531"}}, "ref-text": "viii", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Temesgen", "ce:indexed-name": "Temesgen Z."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Beri", "ce:indexed-name": "Beri G."}]}, "ref-sourcetitle": "Immunol Allergy Clin North Am"}}, {"ref-fulltext": "Forget E J, Menzies D. Adverse reactions to first-line antituberculosis drugs. Expert Opin Drug Saf 2006; 5: 231-249.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Adverse reactions to first-line antituberculosis drugs"}, "refd-itemidlist": {"itemid": {"$": "33644902345", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "5"}, "pagerange": {"@first": "231", "@last": "249"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.J.", "@_fa": "true", "ce:surname": "Forget", "ce:indexed-name": "Forget E.J."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Menzies", "ce:indexed-name": "Menzies D."}]}, "ref-sourcetitle": "Expert Opin Drug Saf"}}, {"ref-fulltext": "Pozniak A L, MacLeod G A, Mahari M, Legg W, Weinberg J. The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa. AIDS Lond Engl 1992; 6: 809-814.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "1992"}, "ref-title": {"ref-titletext": "The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa"}, "refd-itemidlist": {"itemid": {"$": "0026749286", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "809", "@last": "814"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.L.", "@_fa": "true", "ce:surname": "Pozniak", "ce:indexed-name": "Pozniak A.L."}, {"@seq": "2", "ce:initials": "G.A.", "@_fa": "true", "ce:surname": "MacLeod", "ce:indexed-name": "MacLeod G.A."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Mahari", "ce:indexed-name": "Mahari M."}, {"@seq": "4", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Legg", "ce:indexed-name": "Legg W."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Weinberg", "ce:indexed-name": "Weinberg J."}]}, "ref-sourcetitle": "AIDS Lond Engl"}}, {"ref-fulltext": "Nunn P, Gicheha C, Hayes R, et al. Cross-sectional survey of HIV infection among patients with tuberculosis in Nairobi, Kenya. Int J Tuberc Lung Dis 1992; 73: 45-51.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "1992"}, "ref-title": {"ref-titletext": "Cross-sectional survey of HIV infection among patients with tuberculosis in Nairobi, Kenya"}, "refd-itemidlist": {"itemid": {"$": "0026608331", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "73"}, "pagerange": {"@first": "45", "@last": "51"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Nunn", "ce:indexed-name": "Nunn P."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Gicheha", "ce:indexed-name": "Gicheha C."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Hayes", "ce:indexed-name": "Hayes R."}], "et-al": null}, "ref-sourcetitle": "Int J Tuberc Lung Dis"}}, {"ref-fulltext": "Chintu C, Luo C, Bhat G, Raviglione M, DuPont H, Zumla A. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I. Arch Dis Child 1993; 68: 665-668.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "1993"}, "ref-title": {"ref-titletext": "Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I"}, "refd-itemidlist": {"itemid": {"$": "0027194181", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "68"}, "pagerange": {"@first": "665", "@last": "668"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Chintu", "ce:indexed-name": "Chintu C."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Luo", "ce:indexed-name": "Luo C."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Bhat", "ce:indexed-name": "Bhat G."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Raviglione", "ce:indexed-name": "Raviglione M."}, {"@seq": "5", "ce:initials": "H.", "@_fa": "true", "ce:surname": "DuPont", "ce:indexed-name": "DuPont H."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Zumla", "ce:indexed-name": "Zumla A."}]}, "ref-sourcetitle": "Arch Dis Child"}}, {"ref-fulltext": "Montastruc J-L, Lapeyre-Mestre M, Bagheri H, Fooladi A. Gender differences in adverse drug reactions: analysis of spontaneous reports to a regional pharmacovigilance centre in France. Fundam Clin Pharmacol 2002; 16: 343-346.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Gender differences in adverse drug reactions: Analysis of spontaneous reports to a regional pharmacovigilance centre in France"}, "refd-itemidlist": {"itemid": {"$": "0036433092", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "343", "@last": "346"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.-L.", "@_fa": "true", "ce:surname": "Montastruc", "ce:indexed-name": "Montastruc J.-L."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lapeyre-Mestre", "ce:indexed-name": "Lapeyre-Mestre M."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Bagheri", "ce:indexed-name": "Bagheri H."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Fooladi", "ce:indexed-name": "Fooladi A."}]}, "ref-sourcetitle": "Fundam Clin Pharmacol"}}, {"ref-fulltext": "Roujeau J-C. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123-129.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Clinical heterogeneity of drug hypersensitivity"}, "refd-itemidlist": {"itemid": {"$": "17644375873", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "209"}, "pagerange": {"@first": "123", "@last": "129"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.-C.", "@_fa": "true", "ce:surname": "Roujeau", "ce:indexed-name": "Roujeau J.-C."}]}, "ref-sourcetitle": "Toxicology"}}, {"ref-fulltext": "Roujeau J C, Stern R S. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "1994"}, "ref-title": {"ref-titletext": "Severe adverse cutaneous reactions to drugs"}, "refd-itemidlist": {"itemid": {"$": "0028077408", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "331"}, "pagerange": {"@first": "1272", "@last": "1285"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Roujeau", "ce:indexed-name": "Roujeau J.C."}, {"@seq": "2", "ce:initials": "R.S.", "@_fa": "true", "ce:surname": "Stern", "ce:indexed-name": "Stern R.S."}]}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Asero R. Detection of patients with multiple drug allergy syndrome by elective tolerance tests. Am Coll Allergy Asthma Immunol 1998; 80: 185-188.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Detection of patients with multiple drug allergy syndrome by elective tolerance tests"}, "refd-itemidlist": {"itemid": {"$": "0031952752", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "80"}, "pagerange": {"@first": "185", "@last": "188"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Asero", "ce:indexed-name": "Asero R."}]}, "ref-sourcetitle": "Am Coll Allergy Asthma Immunol"}}, {"ref-fulltext": "Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001; 1: 305-310.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Epidemiology of drug allergy"}, "refd-itemidlist": {"itemid": {"$": "0035436482", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "1"}, "pagerange": {"@first": "305", "@last": "310"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Demoly", "ce:indexed-name": "Demoly P."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Bousquet", "ce:indexed-name": "Bousquet J."}]}, "ref-sourcetitle": "Curr Opin Allergy Clin Immunol"}}, {"ref-fulltext": "Guglielmi L, Guglielmi P, Demoly P. Drug hypersensitivity: epidemiology and risk factors. Curr Pharm Des 2006; 12: 3309-3312.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Drug hypersensitivity: Epidemiology and risk factors"}, "refd-itemidlist": {"itemid": {"$": "33748526824", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "3309", "@last": "3312"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Guglielmi", "ce:indexed-name": "Guglielmi L."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Guglielmi", "ce:indexed-name": "Guglielmi P."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Demoly", "ce:indexed-name": "Demoly P."}]}, "ref-sourcetitle": "Curr Pharm des"}}, {"ref-fulltext": "Marks D J B, Dheda K, Dawson R, Ainslie G, Miller R F. Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs. Int J STD AIDS 2009; 20: 339-345.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Adverse events to antituberculosis therapy: Influence of HIV and antiretroviral drugs"}, "refd-itemidlist": {"itemid": {"$": "66349116555", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "339", "@last": "345"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.J.B.", "@_fa": "true", "ce:surname": "Marks", "ce:indexed-name": "Marks D.J.B."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Dheda", "ce:indexed-name": "Dheda K."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Dawson", "ce:indexed-name": "Dawson R."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Ainslie", "ce:indexed-name": "Ainslie G."}, {"@seq": "5", "ce:initials": "R.F.", "@_fa": "true", "ce:surname": "Miller", "ce:indexed-name": "Miller R.F."}]}, "ref-sourcetitle": "Int J STD AIDS"}}, {"ref-fulltext": "World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009. 420. Geneva, Switzerland: WHO, 2010.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "refd-itemidlist": {"itemid": {"$": "70349638608", "@idtype": "SGR"}}, "ref-text": "World Health Organization. 4th ed. WHO/HTM/TB/2009. 420. Geneva, Switzerland: WHO", "ref-sourcetitle": "Treatment of Tuberculosis: Guidelines"}}, {"ref-fulltext": "US Department of Health And Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 4. 03. Bethesda, MD, USA: NIH, 2010.", "@id": "19", "ref-info": {"refd-itemidlist": {"itemid": {"$": "85015255149", "@idtype": "SGR"}}, "ref-text": "US Department of Health And Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 4. 03. Bethesda, MD, USA: NIH, 2010"}}, {"ref-fulltext": "World Health Organization. Definitions and reporting framework for tuberculosis. WHO/HTM/TB/2013. 2. Geneva, Switzerland: WHO, 2013. http://www. who. int/tb/publications/ definitions/en/ Accessed November 2016.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-website": {"ce:e-address": {"$": "http://www.who.int/tb/publications/definitions/en/", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "84888101858", "@idtype": "SGR"}}, "ref-text": "World Health Organization.. WHO/HTM/TB/2013. 2. Geneva, Switzerland: WHO, Accessed November 2016", "ref-sourcetitle": "Definitions and Reporting Framework for Tuberculosis"}}, {"ref-fulltext": "National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-S266.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification"}, "refd-itemidlist": {"itemid": {"$": "0036176161", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "39"}, "pagerange": {"@first": "S1", "@last": "S266"}}, "ref-text": "National Kidney Foundation", "ref-sourcetitle": "Am J Kidney Dis"}}, {"ref-fulltext": "Kuaban C, Bercion R, Koula-Shiro S. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon. Cent Afr J Med 1998; 44: 34-37.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon"}, "refd-itemidlist": {"itemid": {"$": "0031867757", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "44"}, "pagerange": {"@first": "34", "@last": "37"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Kuaban", "ce:indexed-name": "Kuaban C."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Bercion", "ce:indexed-name": "Bercion R."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Koula-Shiro", "ce:indexed-name": "Koula-Shiro S."}]}, "ref-sourcetitle": "Cent Afr J Med"}}, {"ref-fulltext": "Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003; 167: 1472-1477.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis"}, "refd-itemidlist": {"itemid": {"$": "0038471208", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "167"}, "pagerange": {"@first": "1472", "@last": "1477"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Yee", "ce:indexed-name": "Yee D."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Valiquette", "ce:indexed-name": "Valiquette C."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Pelletier", "ce:indexed-name": "Pelletier M."}, {"@seq": "4", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Parisien", "ce:indexed-name": "Parisien I."}, {"@seq": "5", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Rocher", "ce:indexed-name": "Rocher I."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Menzies", "ce:indexed-name": "Menzies D."}]}, "ref-sourcetitle": "Am J Respir Crit Care Med"}}, {"ref-fulltext": "Hurwitz N. Predisposing factors in adverse reactions to drugs. Br Med J 1969; 1: 536-539.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "1969"}, "ref-title": {"ref-titletext": "Predisposing factors in adverse reactions to drugs"}, "refd-itemidlist": {"itemid": {"$": "0014481661", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "1"}, "pagerange": {"@first": "536", "@last": "539"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Hurwitz", "ce:indexed-name": "Hurwitz N."}]}, "ref-sourcetitle": "Br Med J"}}, {"ref-fulltext": "Wanat K A, Anadkat M J, Klekotka P A. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole. J Am Acad Dermatol 2009; 60: 589-594.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole"}, "refd-itemidlist": {"itemid": {"$": "61849156846", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "60"}, "pagerange": {"@first": "589", "@last": "594"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.A.", "@_fa": "true", "ce:surname": "Wanat", "ce:indexed-name": "Wanat K.A."}, {"@seq": "2", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Anadkat", "ce:indexed-name": "Anadkat M.J."}, {"@seq": "3", "ce:initials": "P.A.", "@_fa": "true", "ce:surname": "Klekotka", "ce:indexed-name": "Klekotka P.A."}]}, "ref-sourcetitle": "J Am Acad Dermatol"}}, {"ref-fulltext": "Dibbern D A, Montanaro A. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Am Coll Allergy Asthma Immunol 2008; 100: 91-111.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Allergies to sulfonamide antibiotics and sulfur-containing drugs"}, "refd-itemidlist": {"itemid": {"$": "39049150437", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "100"}, "pagerange": {"@first": "91", "@last": "111"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.A.", "@_fa": "true", "ce:surname": "Dibbern", "ce:indexed-name": "Dibbern D.A."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Montanaro", "ce:indexed-name": "Montanaro A."}]}, "ref-sourcetitle": "Am Coll Allergy Asthma Immunol"}}, {"ref-fulltext": "Choquet-Kastylevsky G, Vial T, Descotes J. Allergic adverse reactions to sulfonamides. Curr Allergy Asthma Rep 2002; 2: 16-25.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Allergic adverse reactions to sulfonamides"}, "refd-itemidlist": {"itemid": {"$": "0036358718", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "16", "@last": "25"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Choquet-Kastylevsky", "ce:indexed-name": "Choquet-Kastylevsky G."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Vial", "ce:indexed-name": "Vial T."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Descotes", "ce:indexed-name": "Descotes J."}]}, "ref-sourcetitle": "Curr Allergy Asthma Rep"}}, {"ref-fulltext": "Adam J, Pichler W J, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol 2011; 71: 701-707.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Delayed drug hypersensitivity: Models of T-cell stimulation"}, "refd-itemidlist": {"itemid": {"$": "79953664999", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "71"}, "pagerange": {"@first": "701", "@last": "707"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Adam", "ce:indexed-name": "Adam J."}, {"@seq": "2", "ce:initials": "W.J.", "@_fa": "true", "ce:surname": "Pichler", "ce:indexed-name": "Pichler W.J."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Yerly", "ce:indexed-name": "Yerly D."}]}, "ref-sourcetitle": "Br J Clin Pharmacol"}}, {"ref-fulltext": "Pichler W J, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D. Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Med Clin North Am 2010; 94: 645-664, xv.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Drug hypersensitivity reactions: Pathomechanism and clinical symptoms"}, "refd-itemidlist": {"itemid": {"$": "77953568669", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "94"}, "pagerange": {"@first": "645", "@last": "664"}}, "ref-text": "xv", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.J.", "@_fa": "true", "ce:surname": "Pichler", "ce:indexed-name": "Pichler W.J."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Adam", "ce:indexed-name": "Adam J."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Daubner", "ce:indexed-name": "Daubner B."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Gentinetta", "ce:indexed-name": "Gentinetta T."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Keller", "ce:indexed-name": "Keller M."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Yerly", "ce:indexed-name": "Yerly D."}]}, "ref-sourcetitle": "Med Clin North Am"}}, {"ref-fulltext": "Smith K J, Skelton H G, Yeager J, Ledsky R, Ng T H,Wagner K F. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Clin Exp Dermatol 1997; 22: 118-123.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Increased drug reactions in HIV-1-positive patients: A possible explanation based on patterns of immune dysregulation seen in HIV-1 disease"}, "refd-itemidlist": {"itemid": {"$": "0030796421", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "22"}, "pagerange": {"@first": "118", "@last": "123"}}, "ref-text": "The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR)", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.J.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith K.J."}, {"@seq": "2", "ce:initials": "H.G.", "@_fa": "true", "ce:surname": "Skelton", "ce:indexed-name": "Skelton H.G."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Yeager", "ce:indexed-name": "Yeager J."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Ledsky", "ce:indexed-name": "Ledsky R."}, {"@seq": "5", "ce:initials": "T.H.", "@_fa": "true", "ce:surname": "Ng", "ce:indexed-name": "Ng T.H."}, {"@seq": "6", "ce:initials": "K.F.", "@_fa": "true", "ce:surname": "Wagner", "ce:indexed-name": "Wagner K.F."}]}, "ref-sourcetitle": "Clin Exp Dermatol"}}, {"ref-fulltext": "Veenstra J, Veugelers P J, Keet I P, et al. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis. Infect Dis Soc Am 1997; 24: 936-941.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis"}, "refd-itemidlist": {"itemid": {"$": "0030986105", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "936", "@last": "941"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Veenstra", "ce:indexed-name": "Veenstra J."}, {"@seq": "2", "ce:initials": "P.J.", "@_fa": "true", "ce:surname": "Veugelers", "ce:indexed-name": "Veugelers P.J."}, {"@seq": "3", "ce:initials": "I.P.", "@_fa": "true", "ce:surname": "Keet", "ce:indexed-name": "Keet I.P."}], "et-al": null}, "ref-sourcetitle": "Infect Dis Soc Am"}}, {"ref-fulltext": "Ormerod L P, Horsfield N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Int J Tuberc Lung Dis 1996; 77: 37-42.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "1996"}, "ref-title": {"ref-titletext": "Frequency and type of reactions to antituberculosis drugs: Observations in routine treatment"}, "refd-itemidlist": {"itemid": {"$": "0030025195", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "77"}, "pagerange": {"@first": "37", "@last": "42"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.P.", "@_fa": "true", "ce:surname": "Ormerod", "ce:indexed-name": "Ormerod L.P."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Horsfield", "ce:indexed-name": "Horsfield N."}]}, "ref-sourcetitle": "Int J Tuberc Lung Dis"}}, {"ref-fulltext": "TanWC, Ong C K, Kang S C L, RazakMA. Two years review of cutaneous adverse drug reaction from first line antituberculous drugs. Med J Malaysia 2007; 62: 143-146.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Two years review of cutaneous adverse drug reaction from first line antituberculous drugs"}, "refd-itemidlist": {"itemid": {"$": "34547646137", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "62"}, "pagerange": {"@first": "143", "@last": "146"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.C.", "@_fa": "true", "ce:surname": "Tan", "ce:indexed-name": "Tan W.C."}, {"@seq": "2", "ce:initials": "C.K.", "@_fa": "true", "ce:surname": "Ong", "ce:indexed-name": "Ong C.K."}, {"@seq": "3", "ce:initials": "S.C.L.", "@_fa": "true", "ce:surname": "Kang", "ce:indexed-name": "Kang S.C.L."}, {"@seq": "4", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Razak", "ce:indexed-name": "Razak M.A."}]}, "ref-sourcetitle": "Med J Malaysia"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60020352", "affilname": "Vajira Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020352", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-85015255304", "dc:description": "OBJ E CTIVE S : Tuberculosis (TB) is a major cause of morbidity and mortality in human immunodeficiency virus (HIV) infected patients. However, anti-tuberculosis drugs can cause cutaneous adverse drug reactions (CADRs). This study was conducted to evaluate differences in CADR incidence between low and high CD4 cell count in patients with low and high CD4 cell count and to identify other risk factors for CADR in HIV-TB co-infected patients. DESIGN: In a retrospective cohort of adult HIV-TB coinfected patients receiving standard anti-tuberculosis treatment between January 2008 and December 2015 at Vajira Hospital, Bangkok, Thailand, baseline demographic, clinical characteristics and factors associated with CADRs, including CD4 cell count status, were collected. RESULT S : Of 307 patients enrolled, CADRs occurred in 48 during the 6-month period of anti-tuberculosis treatment (incidence rate 0.41 events/person-year). Maculopapular rash was the most prevalent CADR. Low CD4 cell count was not associated with CADRs. Cox regression analysis revealed that moderate decrease in the glomerular filtration rate, history of drug hypersensitivity and concomitant cotrimoxazole use were all associated with CADRs. Concomitant antiretroviral therapy usewas associatedwith lower risk of CADRs.No difference in the time to CADRs between patients with lower and higher CD4 cell count could be demonstrated. CONCLUS ION: CADRs are common in HIV-TB coinfected patients. Early recognition and prompt withdrawal of the offending agent can prevent complications and improve TB care.", "pubmed-id": "28225346", "prism:coverDate": "2017-03-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85015255304", "dc:creator": {"author": [{"preferred-name": {"ce:given-name": "L.", "ce:initials": "L.", "ce:surname": "Boonyagars", "ce:indexed-name": "Boonyagars L."}, "@seq": "1", "ce:initials": "L.", "@_fa": "true", "affiliation": {"@id": "60020352", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020352"}, "ce:surname": "Boonyagars", "@auid": "57193608347", "author-url": "https://api.elsevier.com/content/author/author_id/57193608347", "ce:indexed-name": "Boonyagars L."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85015255304"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85015255304&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85015255304&origin=inward"}], "source-id": "18502", "citedby-count": "11", "prism:volume": "21", "subtype": "ar", "dc:title": "CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients", "openaccess": "0", "prism:issn": "18157920 10273719", "publishercopyright": "\u00a9 2017 The Union.", "prism:issueIdentifier": "3", "subtypeDescription": "Article", "prism:publicationName": "International Journal of Tuberculosis and Lung Disease", "prism:pageRange": "338-344", "prism:endingPage": "344", "openaccessFlag": "false", "prism:doi": "10.5588/ijtld.16.0425", "prism:startingPage": "338", "dc:identifier": "SCOPUS_ID:85015255304", "dc:publisher": "International Union against Tubercul. and Lung Dis.journal@the.union.org"}, "idxterms": {"mainterm": [{"$": "Adolescent", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "AIDS-Related Opportunistic Infections", "@weight": "b", "@candidate": "n"}, {"$": "Anti-HIV Agents", "@weight": "b", "@candidate": "n"}, {"$": "Antitubercular Agents", "@weight": "b", "@candidate": "n"}, {"$": "CD4 Lymphocyte Count", "@weight": "b", "@candidate": "n"}, {"$": "Cohort Studies", "@weight": "b", "@candidate": "n"}, {"$": "Drug Eruptions", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Follow-Up Studies", "@weight": "b", "@candidate": "n"}, {"$": "HIV Infections", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Incidence", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Retrospective Studies", "@weight": "b", "@candidate": "n"}, {"$": "Risk Factors", "@weight": "b", "@candidate": "n"}, {"$": "Thailand", "@weight": "b", "@candidate": "n"}, {"$": "Trimethoprim, Sulfamethoxazole Drug Combination", "@weight": "b", "@candidate": "n"}, {"$": "Tuberculosis", "@weight": "b", "@candidate": "n"}, {"$": "Young Adult", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "AIDS"}, {"@_fa": "true", "$": "Drug allergy"}, {"@_fa": "true", "$": "Mycobacterial infection"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pulmonary and Respiratory Medicine", "@code": "2740", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Infectious Diseases", "@code": "2725", "@abbrev": "MEDI"}]}, "authors": {"author": [{"preferred-name": {"ce:given-name": "L.", "ce:initials": "L.", "ce:surname": "Boonyagars", "ce:indexed-name": "Boonyagars L."}, "@seq": "1", "ce:initials": "L.", "@_fa": "true", "affiliation": {"@id": "60020352", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020352"}, "ce:surname": "Boonyagars", "@auid": "57193608347", "author-url": "https://api.elsevier.com/content/author/author_id/57193608347", "ce:indexed-name": "Boonyagars L."}, {"preferred-name": {"ce:given-name": "P.", "ce:initials": "P.", "ce:surname": "Hirunwiwatkul", "ce:indexed-name": "Hirunwiwatkul P."}, "@seq": "2", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Hirunwiwatkul", "@auid": "6603372095", "author-url": "https://api.elsevier.com/content/author/author_id/6603372095", "ce:indexed-name": "Hirunwiwatkul P."}, {"preferred-name": {"ce:given-name": "C. P.", "ce:initials": "C.P.", "ce:surname": "Hurst", "ce:indexed-name": "Hurst C.P."}, "@seq": "3", "ce:initials": "C.P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Hurst", "@auid": "14013748700", "author-url": "https://api.elsevier.com/content/author/author_id/14013748700", "ce:indexed-name": "Hurst C.P."}]}}}